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A B S T R A C T
Endoscopic ultrasonography (EUS) has recently emerged as an alternative means of 
providing data for patients with portal hypertension that is more accurate, less inva-
sive and reproducible. It is well established that video-echo endoscopy, with combined 
endoscopic and sonographic examination, is comparable to endoscopy in diagnosing 
esophageal varices, but is more sensitive in diagnosing the presence of gastric varices. 
Dilated venous abnormalities outside the gastroesophageal lumen, which cannot be 
diagnosed by endoscopy, are readily visible by means of EUS or miniature probes. In 
the clinical setting of portal hypertension, endoscopic ultrasonography is also use-
ful to predict the risk of variceal recurrence or rebleeding, which cannot be reliably 
predicted using endoscopy alone. The introduction of echo endoscopes equipped 
with Doppler facilities together with the performance of haemodynamic studies has 
allowed sonographic visualization of the vessels, playing thus an important role in the 
management of cirrhotic patients. It has thus become feasible not only to assess the 
vascular blood flow but also to evaluate possible morphologic and haemodynamic 
changes of the vessels after endoscopic or pharmacologic therapy. It is, nowadays, 
obvious that EUS is an exciting technological advance that has established its posi-
tion in the diagnosis of varices and cirrhosis; what lies ahead for EUS is to positively 
find application in predicting the risk of variceal bleeding and in managing portal 
hypertension.
I N T R O D U C T I O N
Over the past two decades, endoscopic ultrasonography (EUS) has undergone a 
transition from being a novel imaging technique to becoming a clinical diagnostic test 
that is necessary for the optimal management of gastrointestinal diseases. Along with 
established clinical indications, such as gastrointestinal and pancreatic tumor staging, 
differential diagnosis of submucosal lesions, evaluation of solid and cystic pancreatic 
masses, detection of lymph nodes and fine needle aspiration (FNA), new applications 
have been suggested. Of great interest has been the effort of endosonographers to 
define a clinical role for EUS in portal hypertension.
Since its first use in the assessment of patients with portal hypertension in the 
mid-1980s [1], many conflicting studies have been published. Nowadays, EUS has an 
established role in diagnosing varices and portal hypertension, and assessing the risk 
of recurrent varices and variceal hemorrhage as well as in evaluating the success of 
pharmacologic, endoscopic and shunt therapy for portal hypertension.
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E U S  F O R  T H E  D I A G N O S I S  O F  V A R I C E S  
A N D  P O R T A L  H Y P E R T E N S I O N
The venous anatomy of the lower esophagus is composed 
of four layers: intraepithelial channels, superficial venous 
plexus, deep submucosal veins and adventitial veins radiat-
ing from the inner esophageal mucosa to the outer layer [2]. 
The innermost venous plexus communicates with the extrinsic 
plexus via perforating veins [3], which are commonly present 
1-5 cm above the gastroesophageal junction. These, in turn, 
drain into the tributaries of either the portal or the azygos 
veins. Development of portal hypertension causes diversion 
of blood from the drainage bed of the portal vein to that of 
the azygos system, causing engorgement of all the previous 
channels. Thus, the dilated deep submucosal veins are seen 
as variceal columns and the dilated adventitial veins form 
paraesophageal varices.
Currently, the most widely accepted modality for screen-
ing gastroesophageal varices is esophagogastroduodenoscopy 
(EGD), which, however, may be subjected to high interob-
server variation in the assessment of variceal size [4-5], lacks 
sensitivity in the diagnosis of gastric varices [6,7] and, finally, 
cannot assess the variceal wall thickness. The results of the 
older large-bore fiberoptic echo endoscope and the use of the 
balloon-insufflation technique, which caused esophageal wall 
compression resulting in lower sensitivity of EUS in detecting 
esophageal varices, were disappointing [7,8]. EUS was able to 
demonstrate only 14-25% of grade I, 73-78% of grade II and 
50-89% of grade III of endoscopically confirmed esophageal 
varices [7,8]. With advances in technology, the new genera-
tion video-echo endoscope has a significantly reduced scope 
diameter, and an improvement in ease of scope manipula-
tion and endoscopic image. Thus, by directly visualizing the 
esophageal lumen rather than relying only on sonographic 
examination, the diagnosis of esophageal varices has been 
enhanced. As shown in a recent study [6], EUS seems to be 
as good as EGD for the screening of esophageal varices with 
a sensitivity, specificity, PPV and NPV rate of 96.4%, 95.8%, 
96.4% and 95.8%, respectively (Table 1). Moreover, in the 
same study, the superiority of EUS in detecting gastric varices 
in comparison to EGD was once more demonstrated [8-10]. 
Using EUS as the gold standard, the sensitivity, specificity, 
PPV and NPV rates of EGD in the diagnosis of gastric varices 
were 43.8%, 94.4%, 77.8% and 79.1%, respectively (Table 1). 
Finally, the use of high-frequency (20 MHz) miniature US 
probes can also increase the sensitivity of detecting gastro-
esophageal varices [11].
Apart from the gastroesophageal varices, portal hyperten-
sion causes engorgement and increased blood flow in the col-
laterals vessels surrounding the lower esophagus and proximal 
stomach outside the esophageal wall. The collateral veins are 
divided in peri-esophageal (peri-ECV), located adjacent to 
the muscularis externa of the esophagus and para-esophageal 
(para-ECV), external to the esophageal wall, and in no con-
tact with the muscularis externa. Similarly, collateral veins 
surrounding the proximal stomach are divided in peri-gastric 
(peri-GCV) and para-gastric collateral veins (para-GCV). 
Veins connecting peri-ECVs with para-ECVs are called con-
necting veins, whereas those, connecting esophageal varices 
with peri-ECVs, are the perforating veins. Although these 
vessels have been examined by percutaneous transhepatic 
portography [2], the latter is an invasive method which, in 
addition, is unable to differentiate the submucosal varices from 
peri-ECVs. Similarly, routine CT is highly costly and not very 
sensitive in detecting paraesophageal varices [12-13]. With 
the availability of better instrumentation, both the anatomy 
and physiology of the venous circulation of the esophagus 
and stomach can be characterized with relative clarity by 
endoscopic ultrasonography [6,14-16]. Based on the venous 
abnormalities, it was found that the sensitivity, specificity, PPV 
and NPV rates of EUS in the diagnosis of portal hypertension 
were 92.3%, 94.6%, 84.2% and 97.5%, respectively, whereas 
the sensitivity, specificity, PPV and NPV rates of EGD alone 
were 57.7%, 100%, 100% and 88.3% (Table 2), as EGD does 
not detect the extraluminal vascular changes that occur in pa-
tients with portal hypertension [6]. These results were echoed 
in another study, where the presence of peri-ECVs was 97% 
sensitive and 97% specific for cirrhosis, a diagnostic yield sig-
nificantly better than endoscopy, which identified esophageal 
varices in only 74% of patients with cirrhosis [16]. Moreover, 
it was shown that the higher the variceal size at endoscopy, 
the more readily visualized were the peri-ECVs at EUS, in 
contrast to the para-ECVs, where no significant correlation 
was observed [15]. This is in contrast to a more recent study, 
TABLE 1. EUS and EGD in diagnosing esophageal (EV) 
and gastric (GV) varices respectively
 Sensitivity Specificity PPV NPV
EUS in diagnosing EV 96.4% 95.8% 96.4% 95.8%
EGD in diagnosing GV 43.8% 94.4% 77.8% 79.1%
EGD = Esophagogastroduodenoscopy, EUS = Endoscopic 
Ultrasonography, EV = Esophageal varices, GV = Gastric varices
TABLE 2. EUS and EGD in diagnosing portal hyper-
tension
 Sensitivity Specificity PPV NPV
EUS 92.3% 94.6% 84.2% 97.5%
EGD 57.7% 100% 100% 88.3%
EUS = Endoscopic Ultrasonography, EGD = Esophagogastroduoden
oscopy, PPV = Positive Predictive Value, NPV = Negative Predictive 
Value
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which showed that both para-ECVs and peri-ECVs were as-
sociated with larger esophageal varices [6]. This discrepancy 
was attributed to the largest sample size and to the use of the 
echo endoscope rather than the miniature ultrasound probe, 
which may underestimate the prevalence and degree of para-
ECVs due to the limited penetration depth. The latter study 
additionally demonstrated a positive correlation between the 
size of peri-ECV and para-ECV with the Child-Pugh grading 
of cirrhosis and between the grade of gastric varices with the 
size of para-GCV and peri-GCV and confirmed previous data 
about the strong association between the perforating veins and 
the size of esophageal and gastric varices.
Another difference between cirrhotic and noncirrhotic 
patients recognized by EUS, was the thickness of gastric 
mucosa and submucosa, which was found to be greater in 
cirrhotic patients, reflecting the relative outflow obstruction 
of venous and lymphatic flow in these patients [16].
The dilation of the azygos vein is an issue that has provoked 
many controversies. Although it has been reported that portal 
hypertension causes dilation of splenic vein, portal vein and 
superior mesenteric vein when comparing EUS findings in 
cirrhotic and noncirrhotic patients, it has no significant influ-
ence on the diameter of the azygos vein [8]. This was validated 
subsequently, where patients with more severe liver disease 
did not have significantly larger azygos vein diameters [17]. 
On the contrary, other studies showed a significant dilation 
of the azygos vein in cirrhosis [7,16,18], as it constitutes the 
main drainage pathway for the superior portosystemic col-
lateral circulation.
Another sign of portal hypertension, identifiable by EUS 
seems to be the dilation of the thoracic duct [8,16,19]. The 
hepatic venous outflow obstruction and increased hepatic 
lymph formation cause distention of the hilar lymphatics, re-
sulting in increase of lymph flow through the thoracic duct. 
Even though the dilation of the thoracic duct was found only 
in patients with ascites and varices [19], a larger sample size 
must be evaluated in order to identify differences between 
subgroups of cirrhotic patients. Nonetheless, EUS may be use-
ful for studying the thoracic duct in determining its potential 
role in ascites formation.
EUS can also be used for the detection of rectal varices. 
As it was shown [20], prevalence of rectal varices was 43.3% 
on endoscopy and 75% on EUS whereas congestive rectopa-
thy was found in 38.3% of patients. These vascular changes 
seemed to be influenced by sclerotherapy, but not by the 
grade of esophageal varices, Endosonography has been used 
in the evaluation of cirrhotic patients. by the cause of portal 
hypertension, or by the severity of liver disease.
It is of great importance, that the new generation linear 
echo endoscopes can evaluate the vascular blood flow, by 
using Duplex or Doppler sonography (CD-EUS). Thus, 
diminished or reversed direction of vascular blood flow or 
even the patency of a vessel or a shunt can be recognized. 
Other methods used to measure the azygos blood flow are 
the invasive thermodilution technique [21] and the MR an-
giography [22], which, although non-invasive, does not allow 
continuous haemodynamic measurement. The haemodynamic 
study of the azygos vein can be easily done by CD-EUS, find-
ing a straight segment of the vein. The character of azygos 
blood flow (AzBF) appears as a smooth venous tracing in 
the spectral display with small fluctuations associated with 
the patient’s breathing [17,18]. Maximal blood flow velocity 
seems to be increased in patients with portal hypertension and 
gastroesophageal varices [18], indicating that AzBF is related 
to the severity of liver disease as reflected in Child-Pugh grad-
ing [17]. The morphology and the blood flow through the left 
gastric vein has been studied with CD-EUS [23] and it was 
shown that, although its diameter increased as the size of the 
varices increased, this increase was not statistically significant. 
It was suggested that the increased hepatofugal flow velocity 
was the most sensitive marker for the development of varices. 
Furthermore, the branching pattern of the left gastric vein, as 
it has been described with left gastric venography [24,25], and 
its relationship with topographic collateral channels, may be 
responsible for directing the blood flow towards varices at the 
level of the proximal stomach. Finally, Duplex endosonography 
can be used to identify the patency of intra-abdominal vessels, 
such as splenic and portal vein, or of a portosystemic shunt 
when transabdominal ultrasound is nondiagnostic in patients 
with suspected thrombosis [26].
E U S  I N  T H E  A S S E S S M E N T  O F  V A R I C E A L  
R E C U R R E N C E  A N D  R E B L E E D I N G
The hepatofugal blood flow velocity in the left gastric vein 
trunk, and its branching pattern, were associated with variceal 
recurrence after endoscopic therapy [23]. After endoscopic 
variceal ligation or sclerotherapy, the increased hepatofugal 
velocity and the anterior branching pattern, documented by 
CD-EUS, were found to be risk factors for recurrence [27]. 
The detection rate and diameter of the perforating veins may 
also be a predictor of variceal reccurence [23].
Endosonographically detected paraesophageal varices are 
excellent indicators of variceal recurrence after endoscopic 
sclerotherapy or ligation [28-30]. Patients with large (>5 
mm) para-ECVs have a greater risk of variceal recurrence 
(93%) and bleeding (43%) than those with small or without 
para-ECVs (46% and 12% respectively) [29] (Table 3). These 
findings were confirmed by subsequent studies [16,30]. It was 
also suggested that the presence of large para-gastric collateral 
veins (maximal diameter >5 mm) may be an additional risk 
factor for a first variceal hemorrhage [16].
Severe type peri-ECVs and large perforating veins were de-
tected endosonographically, three months before endoscopic 
variceal recurrence [31], indicating that these vessels may be 
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ily identify residual gastric varices as submucosal anechoic 
vascular channels with a color Doppler signal. Persistence 
of blood flow, as detected by CD-EUS, is associated with 
a higher failure rate of variceal obliteration by endoscopic 
treatment and with a higher risk of gastric variceal recurrent 
bleeding compared to those without detectable blood flow [43]. 
It is also noteworthy, that patients who underwent repeated 
EUS-guided cyanoacrylate injection had a significantly lower 
risk of rebleeding. Even though the overall mortality rate was 
not significantly changed, it was significantly improved, in 
comparison to the equivalent mortality rate of patients who 
received on-demand injection only at the time of recurrent 
bleeding [43].
E U S  F O R  T H E  E V A L U A T I O N  
O F  T H E  E F F E C T S  O F  P H A R M A C O L O G I C  
T H E R A P Y
As it has been previously mentioned, by using CD-EUS, 
the AzBF was found to have a positive association with the 
severity of liver disease as reflected in Child-Pugh grading 
[17]. A marked reduction in AzBF was documented after 
intravenous injections of terlipressin or somatostatin, being, 
in the case of somatostatin, more dramatic in the first minute 
after bolus injection [17]. These findings were confirmed in 
another study [44], where continuous infusion of somatostatin 
or octreotide was applied so as to assess the effects of these 
drugs in AzBF and in gastric mucosal blood flow. An im-
mediate and transient decrease in AzBF and gastric mucosal 
blood flow was demonstrated during continuous infusion of 
either drug. Somatostatin induced a significant rebound ef-
fect 60 minutes after administration, suggesting a possible 
desensitization phenomenon.
Patients on propranolol or isosorbide-5-mononitrate were 
examined by serial EUS and endoscopic gauge measurement 
to determine the effect of these drugs on variceal volume 
and pressure [35]. It was shown that whereas isosorbide-5-
mononitrate reduced only transmural variceal pressure, in 
the case of propranolol, the overall reduction in the variceal 
wall tension exceeded that contributed by transmural pressure 
change, showing that propranolol reduced not only the variceal 
pressure, but also the variceal column radius and volume.
C O N C L U S I O N S
The current status of non-invasive methods for the assess-
ment of portal haemodynamics and risk of variceal bleeding is 
still unsatisfactory and can not be recommended for routine 
clinical use. HVPG is the best predictor of the efficacy of 
pharmaceutical therapy and along with the endoscopic appear-
ance of varices provide valuable information regarding risk 
used as well, for the early prediction of variceal recurrence 
after endoscopic treatment. Additionally, the presence of 
multiple intramural vessels in the cardia may predict recur-
rence [31,32].
Furthermore, in assessing the risk of variceal bleeding, 
EUS is very useful, as it allows the evaluation of the variceal 
size and variceal wall thickness [33], the measurement of 
intravariceal pressure by direct puncture of the varices [34], 
by using a pressure sensitive gauge [35] or by Doppler-guided 
manometry [36] and the detection of high-risk stigmata of 
varices such as the red hematocystic spot, which can be identi-
fied by miniprobes [37].
E U S  A N D  E N D O S C O P I C  T H E R A P Y  
O F  V A R I C E S
It is well known that varices recur more commonly among 
patients who undergo endoscopic variceal ligation compared 
to those who had sclerotherapy [38,39], as ligation provokes 
mechanical strangulation of the varices in the mucosal and 
submucosal layers, leaving the perforating veins, which join 
the submucosal vascular channels to para-esophageal collat-
eral veins, untouched. On the other hand, sclerotherapy may 
be able to obliterate the perforating veins and feeding veins, 
while chemical irritation caused by the sclerosants induce fi-
brosis and thickening of the inner esophageal wall, preventing 
variceal recurrence.
By using miniprobes, perforating veins can be identified 
and bands can be applied on them, increasing thus the success 
of ligation [40] and the variceal recurrence-free interval [41]. 
Moreover, by using CD-EUS, the sclerosant can be injected 
until the varix is seen to be completely thrombosed, as indi-
cated by the absence of flow on Doppler, or it can be directed 
to the level of the perforating veins [42]. Thus, the number of 
sessions required for obliteration of esophageal varices and the 
recurrence rate may be decreased. Additionally, EUS can be 
of value in detecting residual varices, which are less apparent 
in endoscopy after several sessions of sclerotherapy, because of 
overlying ulceration, edema and formation of pseudopolyps. 
The same stands for the gastric varices, which cannot be easily 
detected endoscopically, mostly after cyanoacrylate injection 
for controlling gastric variceal bleeding [43]. EUS can eas-
TABLE 3. Risk of variceal recurrence and rebleeding 
according to para-ECVs’ size
Size of para-ECVs Variceal Variceal
 recurrence rebleeding
>5 mm 93% 43%
<5 mm 46% 12%
ECV = Esophageal Collateral Veins
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HOSPITAL CHRONICLES 1(1), 2006 ENDOSCOPIC ULTRASONOGRAPHY IN PORTAL HYPERTENSION
41
stratification and management of high-risk patients. However, 
EUS appears promising but requires further evaluation.
EUS can provide significant information regarding the 
morphologic assessment of varices. It is not clear however, 
if variceal wall thickness alone is as accurate a predictor of 
bleeding or whether simultaneous intravariceal pressure mea-
surements should be added in a prognostic model that could 
allow risk stratification based on pathophysiological implica-
tions. Moreover, it is clear that it can be used for risk strati-
fication after endoscopic therapy, but it is not known if this 
approach would be beneficial in clinical practice. Perhaps a 
more strict endoscopic screening should be applied in patients 
with large para-oesophageal collateral veins after endotherapy 
in order to prevent further bleeding episodes, and this could 
be a rather interesting area for future research.
In conclusion, EUS is a valuable imaging method for 
investigating patients with portal hypertension. Although 
its role in the evaluation of bleeding risk and response to 
therapy is still not well defined, the fact is that EUS provides 
an accurate diagnosis, identifies high-risk patients, and allows 
the assessment of success of endoscopic and pharmacologic 
therapies.
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